Skip to main content
. 2015 Feb 11;59(3):1558–1568. doi: 10.1128/AAC.04295-14

TABLE 2.

Protection by treatment in vitro with TRL345 of MRC-5 fibroblasts from infection by clinical isolates of diverse genotypes

Isolate gB serotype group FFU with no antibodya FFU with TRL345
CSL001 1 6 0
32524 1 4 0
32692 1 4 0
32583 2 4 0
32691 2 2 0
32195 2 2 0
32613 3 5 0
32635 3 4 0
CLS006 3 3 0
32516 3 3 0
32493 3 2 0
32514 3 2 0
UXCM NDb 5 0
32648 ND 2 0
32552 ND 1 0
a

Focus-forming units (FFU) were counted at 10 to 12 days postinfection.

b

ND, not determined.